Guidelines for the diagnosis and management of neuropathic pain: consensus of a group of Latin American experts.
These consensus guidelines have been developed by a group of Latin American experts in pain management, to point out patterns and make practical recommendations to guide the diagnosis, identify warning signs (yellow and red flags), and establish comprehensive medical management (pharmacologic and nonpharmacologic treatment) and monitoring plans for patients enduring neuropathic pain. From the viewpoint of pharmacologic management, drugs are classified into groups according to efficacy, availability/accessibility, and safety criteria. Drugs are recommended for use depending on the disease and particular circumstances of each patient, with an approach that favors multimodal treatment while taking into consideration the idiosyncrasies of medical practice in Latin America.
Acevedo
Juan Carlos
JC
Facultad de Medicina, Universidad Javeriana, Bogotá, Colombia.
Amaya
Abraham
A
Casasola
Oscar de León
Ode L
Chinchilla
Nelson
N
De Giorgis
Marcelo
M
Florez
Sandra
S
Genis
Miguel Angel
MA
Gomez-Barrios
Juan Vicente
JV
Hernández
John Jairo
JJ
Ibarra
Eduardo
E
Moreno
Carlos
C
Orrillo
Enrique
E
Pasternak
Danilo
D
Romero
Sabina
S
Vallejo
Mariana
M
Velasco
Maritza
M
Villalobos
Alberto
A
D000700:Analgesics / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007843:Latin America; D009437:Neuralgia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D010147:Pain Measurement; D017410:Practice Guidelines as Topic
D000700:Analgesics